Drax Group PLC

Director's Dealing • Jun 27, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5532D

Drax Group PLC

27 June 2019

27 June 2019

Drax Group plc

("Drax" or "the Company")

Symbol: DRX

Notification of Transactions of Directors,

Persons Discharging Managerial Responsibility or Connected Persons

John Baxter has notified the Company that on 26 June 2019 he purchased 7,000 ordinary shares in Drax at a price of 269 pence per share. Following the transaction, Mr Baxter's total shareholding in the Company is 10,000 ordinary shares.

The information below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation 596/2014 notification and is in respect of ordinary shares of 11 16/29 pence each in the share capital of the Company of which there were 410,013,656 shares in issue at the time of the dealing.

Details of PDMR / person closely associated with them ("PCA")

Name

John Baxter

Reason for the notification

Position / status

Non-Executive Director

Initial notification / amendment

Initial Notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Drax Group plc

LEI

549300YPSNTXR4ZHSR98

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument

Identification code

Ordinary shares of 11 16/29 pence

GB00B1VNSX38

Nature of the transaction

Purchase of shares

Price(s) and volume(s)

Price(s)	Volume(s)
269 pence per share	7,000

Aggregated information

-      Aggregated volume

-      Price

7,000

£18,830.00

Date of the transaction

26.06.2019

Place of the transaction

London Stock Exchange

--ENDS--

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHFFMATMBJTBLL